Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemiaKai Hübel, Andreas Engert, Volker Diehl et al.|Annals of Hematology|1999Cited by 55
Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin’s lymphomaPeter Borchmann, Andreas Engert, R Knippertz et al.|Annals of Oncology|2001Cited by 52